Baudax Bio, Inc.: going-concern / distress — Baudax Bio files Chapter 11 bankruptcy on February 22, 2024

Baudax Bio, Inc.

Filed voluntary Chapter 11 petition in U.S. Bankruptcy Court for Eastern District of Pennsylvania (case #2:24-bk-10583).
Company intends to operate as debtor-in-possession during the case.
No additional details regarding restructuring plan or financing provided in filing.

Key facts

Extracted from this filing and checked against the source text.

Distress & Bankruptcy SEC 8-K Item 1.03 confidence 0.9

Baudax Bio, Inc. entered chapter 11 in U.S. Bankruptcy Court for the Eastern District of Pennsylvania (petition 2024-02-22).

Proceeding: chapter 11
Court: U.S. Bankruptcy Court for the Eastern District of Pennsylvania
Petition: 2024-02-22

Exact text from the filing

On February 22, 2024, Baudax Bio, Inc. (the “Company”) filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy code (the “Bankruptcy Code”) in the U.S. Bankruptcy Court for the Eastern District of Pennsylvania (the “Bankruptcy Court”) (the “Chapter 11 Case”).

View on SEC.gov

Browse all distress & bankruptcy →

Source: SEC EDGAR

accession 0001193125-24-049000

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.